(Bloomberg) — Aetna Inc. has agreed to reduce out-of-pocket payments for most HIV and AIDS medicines after pressure from an advocacy group, revising coverage that had some patients paying $1,000 a month for the drugs.
Before the change, Aetna put almost all HIV drugs in its highest category of cost sharing, asking patients to pay as much as half the expense of high-priced medicines, according to the AIDS Institute. The health insurer will move the drugs into a category that will charge patients $5 to $100 after deductibles are met, the nonprofit institute said Thursday. Cynthia Michener, an Aetna spokeswoman, confirmed the change.
"Aetna's announcement will help ensure that people living with HIV/AIDS throughout the country will have greater access to essential medicines at a more affordable cost," Michael Ruppal, executive director of the AIDS Institute, said in the statement. "However, there are still many other insurers who are charging patients excessive costs for their HIV medications."
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.